of other agents, we conditionally recommend against RAL due to harms of VTE and fatal stroke or ROM due to uncertain harms with increased myocardial infarction, stroke and death. We conditionally recommended against RAL due to harms of VTE and fatal stroke or ROM due to uncertain harms including increased myocardial infarction, stroke and death (eg, age at diagnosis, growth, body mass index [BMI], disease severity, GC dosing, BMD, symptomatic or asymptomatic vertebral compression fractures)